-
AstraZeneca furthers ambition to transform outcomes in early lung cancer and redefine metastatic breast cancer treatment at ASCO 2024
22 May 2024 11:18 GMT
… (EGFRm) non-small cell lung cancer (NSCLC) after chemoradiotherapy (CRT … across earlier-stage lung cancer settings
Several presentations …
Presentation details (CDT)
Lung Cancers
Ramalingam, SS
Osimertinib (osi … 3 weeks or either irinotecan (N=55) 150 …
-
Onivyde May Have Similar Survival Outcomes as Chemo in Small Cell Lung Cancer
21 May 2024 22:33 GMT
… relapsed small cell lung cancer (SCLC), receiving Onivyde (liposomal irinotecan) as second-line … .
For patients with small cell lung cancer, Bunn noted that there are … improve outcomes in small cell lung cancer.”
For more news on cancer …
-
FDA Grants Fast Track Designation for SNB-101 to Treat Small Cell Lung Cancer
13 May 2024 22:24 GMT
… more commonly diagnosed with lung cancer, compared with individuals … an active metabolite of irinotecan that is used in … additional treatment options for lung cancer, pancreatic cancer, and … in individuals related to lung cancer through lung targeting, …
-
Parabacteroides distasonis-Derived Outer Membrane Vesicles Enhance Antitumor Immunity Against Colon Tumors by Modulating CXCL10 and CD8+ T Cells
28 May 2024 09:16 GMT
… are commonly used, including bevacizumab, irinotecan hydrochloride and capecitabine.4 However … efficacy in non-small-cell lung cancer. Acta Pharm Sin B. 2020 …
-
SN Bioscience Receives FDA Fast Track Designation for Small Cell Lung Cancer
10 May 2024 06:51 GMT
… year. Following small cell lung cancer and pancreatic cancer, attempts … an active metabolite of Irinotecan which is gaining attention … to be effective in lung cancer, pancreatic cancer, and … -designation-for-small-cell-lung-cancer-302142057.html
SOURCE SN …
-
S3 Episode 4: Antibody-Drug Conjugates and Lung Cancer
09 May 2024 13:40 GMT
… where we discussed managing lung cancer with neoadjuvant and adjuvant … toxicities. I think irinotecan would certainly be the … for the Medscape InDiscussion Lung Cancer podcast.
Listen to … Antibody-Drug Conjugates for Lung Cancer: Payloads and Progress
…
-
Merck To Showcase Advances In The Science Of Cancer With New Data Presented At ASCO 2024
28 May 2024 03:16 GMT
… metastatic non-small cell lung cancer (NSCLC) harboring METex14 … Encorafenib and cetuximab versus irinotecan/cetuximab or FOLFIRI … ) skipping non-small cell lung cancer with brain, liver, adrenal … N 8575 Session Title: Lung Cancer-Non-Small Cell Metastatic
…
-
Prognostic Nutritional Index Predicts Efficacy and Immune-Related Adverse Events of First-Line Chemoimmunotherapy in Patients with Extensive-Stage Small-Cell Lung Cancer
18 Mar 2024 13:18 GMT
… for Small-Cell Lung Cancer Patients
Association Between … Clinical insights into small cell lung cancer: tumor heterogeneity, diagnosis, … M, et al. Irinotecan plus cisplatin compared with … metastatic small-cell lung cancer (SCLC). Lung Cancer. 2004;45 Suppl …
-
Bristol Myers Squibb Announces Acceptance of U.S. and EU Regulatory Filings for Neoadjuvant Opdivo (nivolumab) and Chemotherapy Followed by Surgery and Adjuvant Opdivo in Resectable Non-Small Cell Lung Cancer
07 Feb 2024 12:27 GMT
… to date, including lung cancer, bladder cancer, esophageal … response (MPR).
About Lung Cancer
Lung cancer is the leading … fluoropyrimidine, oxaliplatin, and irinotecan. This indication is … lung cancer; Checkmate 816-neoadjuvant non-small cell lung cancer, …
-
Bristol Myers Squibb to Present Data at ASCO & EHA from More Than 130 Studies Across 25 Diseases Supporting Expansion into New Indications, Demonstrating Long-Term Survival, and Highlighting Novel Modalities and Research Platforms
23 May 2024 21:27 GMT
… Poster
Abstract #8522
Lung cancer—Non-Small Cell Metastatic … positive) non-small cell lung cancer (NSCLC).
OPDIVO® ( … fluoropyrimidine, oxaliplatin, and irinotecan. This indication is … lung cancer; Checkmate 816-neoadjuvant non-small cell lung cancer, …